Search research articles
Contact Us
Filters
Showing results (11-20 of 52) with videos related to
Page
of 6
Sort By:
Methods in Enzymology
|
June 2, 2009
Chapter 9 the duffy antigen receptor for chemokines
Antal Rot, Richard Horuk
Pharmacology & Therapeutics
|
May 17, 2005
The clinical potential of chemokine receptor antagonists
Sofia Ribeiro, Richard Horuk
Current Topics in Medicinal Chemistry
|
June 12, 2010
Small molecule antagonists of chemokine receptors--is promiscuity a virtue?
James E Pease, Richard Horuk
Expert Opinion on Therapeutic Patents
|
May 16, 2009
Chemokine receptor antagonists: part 2
James E Pease, Richard Horuk
Expert Opinion on Therapeutic Patents
|
May 16, 2009
Chemokine receptor antagonists: Part 1
James E Pease, Richard Horuk
Expert Opinion on Investigational Drugs
|
July 19, 2005
CCR1 antagonists in clinical development
James E Pease, Richard Horuk
Trends in Parasitology
|
April 13, 2010
Duffy antigen inhibitors: useful therapeutics for malaria?
Tracy M Handel, Richard Horuk
Trends in Pharmacological Sciences
|
October 9, 2002
Chemokines, chemokine receptors and small-molecule antagonists: recent developments
James J Onuffer, Richard Horuk
Expert Opinion on Drug Discovery
|
March 20, 2014
Recent progress in the development of antagonists to the chemokine receptors CCR3 and CCR4
James Edward Pease, Richard Horuk
Pancreas
|
February 22, 2007
Treatment with BX471, a nonpeptide CCR1 antagonist, protects mice against acute pancreatitis-associated lung injury by modulating neutrophil recruitment
Min He, Richard Horuk, Madhav Bhatia
Page
of 6
Search research articles
Search
Showing results (11-20 of 52) with videos related to
Sort By:
Page
of 6
Methods in Enzymology
|
June 2, 2009
Chapter 9 the duffy antigen receptor for chemokines
Antal Rot, Richard Horuk
Pharmacology & Therapeutics
|
May 17, 2005
The clinical potential of chemokine receptor antagonists
Sofia Ribeiro, Richard Horuk
Current Topics in Medicinal Chemistry
|
June 12, 2010
Small molecule antagonists of chemokine receptors--is promiscuity a virtue?
James E Pease, Richard Horuk
Expert Opinion on Therapeutic Patents
|
May 16, 2009
Chemokine receptor antagonists: part 2
James E Pease, Richard Horuk
Expert Opinion on Therapeutic Patents
|
May 16, 2009
Chemokine receptor antagonists: Part 1
James E Pease, Richard Horuk
Expert Opinion on Investigational Drugs
|
July 19, 2005
CCR1 antagonists in clinical development
James E Pease, Richard Horuk
Trends in Parasitology
|
April 13, 2010
Duffy antigen inhibitors: useful therapeutics for malaria?
Tracy M Handel, Richard Horuk
Trends in Pharmacological Sciences
|
October 9, 2002
Chemokines, chemokine receptors and small-molecule antagonists: recent developments
James J Onuffer, Richard Horuk
Expert Opinion on Drug Discovery
|
March 20, 2014
Recent progress in the development of antagonists to the chemokine receptors CCR3 and CCR4
James Edward Pease, Richard Horuk
Pancreas
|
February 22, 2007
Treatment with BX471, a nonpeptide CCR1 antagonist, protects mice against acute pancreatitis-associated lung injury by modulating neutrophil recruitment
Min He, Richard Horuk, Madhav Bhatia
Page
of 6